This research demonstrates the antiproliferative effects of new compounds on EGFR and BRAF, suggesting enhanced cancer treatment options.
No takes yet. Share an insight, caveat, or question.
Gomaa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: